Genetic examinations list
Filter
Laboratory focus
Diagnostic group
Methods
Clinical expertise code
Tests covered by the reimbursement
Tests without reimbursement
Sex
SOD1 gene testing – familial amyotrophic lateral sclerosis (ALS)
Testing for all coding exons (1, 2, 3, 4, 5) including adjacent SOD1 gene intron sequences by Sanger sequencing.
Material:
Peripheral blood, Buccal swab …Turnover Time:
3 weeksSTATIM
1 weekPABPN1 gene testing (exon 1) – oculopharyngeal muscular dystrophy (OPMD) – familial AD
PCR amplification and sequencing of PABPN1 gene (associated with oculopharyngeal muscular dystrophy) to detect GCG triplet expansion.
Material:
Peripheral blood, Buccal swab …Turnover Time:
3 weeksSTATIM
1 weekMTM1 gene testing – X-linked myotubular myopathy congenital
Sequencing of 14 coding exons in the MTM1 gene.
Material:
Peripheral blood, Buccal swab …Turnover Time:
3 weeksSTATIM
1 weekEXOSC3 gene testing – pontocerebellar hypoplasia type 1 (PCH1)
Sequencing of 1 coding exon in the EXOSC3 gene for PCH1 (pontocerebellar hypoplasia type 1).
Material:
Peripheral blood, Buccal swab …Turnover Time:
3 weeksSTATIM
1 weekMARVELD2 gene testing (exon 4) – early non-syndromic AR deafness
Sequencing the coding region of exon 4 in the MARVELD2 gene, which is a common cause of hearing loss in the Roma ethnic group.
Material:
Peripheral blood, Buccal swab …Turnover Time:
3 weeksSTATIM
1 weekDetermination of TPMT mutation status, allele *1, *2, *3A, *3B, *3C (mutations c.238G>C, c.460G>A and c.719A>G)
TPMT gene testing is performed by PCR and reverse hybridization strip assay to detect *1, *2, *3A, *3B, *3C alleles (c.238G>C, c.460G>A and c.719A>G mutations), which are responsible for the reduced activity of this enzyme catalyzing components of thiopurine drugs used in cancer therapy.